Navigation Links
EAS Congress in Gothenburg, June 26-29
Date:6/27/2011

Many of the most prominent international scientists in the field of atherosclerosis, including scientists from the Sahlgrenska Academy, University of Gothenburg, will attend the EAS Congress in Gothenburg, 26-29 June. They will discuss recent advances in the prevention and treatment of atherosclerosis and associated diseases, such as type 2 diabetes, heart disease and stroke.

The EAS Congress has attracted 2,000 participants from all parts of the world, and several scientists from the Sahlgrenska Academy will take part. One of these is Olov Wiklund, senior professor at the Sahlgrenska Academy, who has taken part in drawing up the first European guidelines that deal specifically with the optimal treatment for elevated blood fat levels. These guidelines will be presented at the congress.

"Publishing the new guidelines is an important event that will affect many people physicians, scientists and patients", says Olov Wiklund.

In addition to presentations of research results, there will be opportunities for young and old colleagues to share experiences and provide feedback on each other's research and work, in the form of daily round-table discussions. Young scientists will have the chance to meet some of the leading researchers in the field, informally and personally. Practical aspects of treatment and diagnosis will also be discussed in several sessions at the congress.

One of the younger scientists from the Sahlgrenska Academy is Fredrik Bckhed, who will describe gut how bacteria can influence our metabolism and health. He will focus on how intestinal bacteria can influence the course of disease in metabolic-related diseases, such as obesity, diabetes and atherosclerosis.

"Since the intestinal flora in a persons gut has 150 times the number of genes that the person has, our work is based on the hypothesis that changes in the intestinal flora can contribute to disease and health. We believe that we can find new diagnostic markers and treatment strategies for these metabolic diseases by altering the composition and/or function of the flora", says Fredrik Bckhed.


'/>"/>

Contact: Camilla Pettersson
camilla.pettersson@wlab.gu.se
46-031-342-6335
University of Gothenburg
Source:Eurekalert

Related medicine news :

1. 24th ECNP Congress: The most promising data from research across brain disorders
2. Success of First World Congress of Pediatric Urology underscores increasing importance of specialty
3. Research!America urges Congress: Support medical research in 2012 budget
4. 24th ECNP Congress Sept. 3-7, 2011, Paris, France
5. Alfred B. Knight, M.D., Scott & White Healthcare, presents at 8th Annual World Health Care Congress
6. Diabetes Surgery 2nd World Congress
7. International Liver Congress 2011
8. 2010 AAAS Philip Hauge Abelson Award presented to the Honorable Rush Holt, Ph.D., for supporting science in Congress
9. ACP says Congress must find common ground to address crisis in our health care system
10. Mammography controversy to be explored at 19th Annual Congress on Womens Health
11. Wounded Congresswoman Breathing on Her Own: Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... Hackensack, N.J. has been honored by Enterprising Women magazine as one of its ... world’s top women business owners. Winners have demonstrated that they have fast-growth businesses, ...
(Date:4/26/2017)... NJ (PRWEB) , ... April 26, 2017 , ... RawTrition ... an easy way to get nutrients from SUPERFOODS! , RawTrition is taking ... at the cellular level because the body recognizes its raw form (unlike the synthetically ...
(Date:4/26/2017)... ... 2017 , ... MYOLYN, a medical technology company dedicated to ... 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two of ... are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation (FES) ...
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition Duchenne, ... Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics on ... clinical trial in Duchenne announced today. , Coalition Duchenne funded studies carried ...
(Date:4/25/2017)... BC (PRWEB) , ... April 25, 2017 , ... The ... from Richmond, BC, who live with dental fear and require sedation to receive dental ... at ease during various procedures, from hygienic cleanings to oral surgery, at their ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  Novartis today announced the publication of ... and Blood Institute (NHLBI) of the National Institutes ... with treatment-naïve severe aplastic anemia (SAA) achieved complete ... at the initiation of and concurrently with standard ... sequential treatment groups, or cohorts. Cohort 3 added ...
(Date:4/18/2017)... 18, 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), ... Urology, Uro/Gyn and Gynecology markets with innovative and proprietary ... ended March 31, 2017 after the market close on ... will host a conference call and webcast to discuss ... 2, 2017 at 4:30 p.m. Eastern Time (3:30 p.m. ...
(Date:4/18/2017)... DIEGO , April 18, 2017  Astute Medical, ... a case series to be presented at the 2017 ... which begins today and continues through April 22. Physicians ... IGFBP-7 , used to assess risk for acute kidney ... decompensated heart failure (ADHF). Elevated levels ...
Breaking Medicine Technology: